Previous RCCPS Speakers and Topics
| Craig Beattie, CDG Therapeutics Noncationic Peptides Obtained from Cupredoxins as Therapeutics and Therapeutic Adjuncts in Human Cancer |
|
| Alan Snow, Proteotech, Inc. Pepticlere: A novel small peptide for the treatment of alzheimer’s disease that markedly reduces brain beta-amyloid protein load and improves memory |
|
| Derek MacClean, KAI Pharmaceuticals Cell Penetrating Peptides In The Clinic: Modulating Protein Kinase C To Treat Ischemia Reperfusion Damage And Pain. |
|
| Jean Rivier, The Salk Institute Hypothalamic Hormone Analogs Come Of Age |
|
| Tomi Sawyer, Aileron Therapeutics Targeting Intracellular Pathways With Stapled Peptides |
|
| Richard Dimarchi, Indiana University KEY NOTE ADDRESS: Emergence of Chemical Biotechnology and its Application to Endocrine Diseases |
|
| Ulo Langel, Stockholm University Applications of Cell-Penetrating Peptides in Oligonucleotide Delivery |
|
| Randall Myrsny, University of Bath Selected Intracellular Peptide Drug Delivery as a Tool to Control Barrier Properties of Polarized Epithelia |
|
| Jamal Temsamani, CLL Pharma Synb Peptide Vetors: A New Approach To Drug Delivery |
|
| Homa Sadeghi, Phase Bio, Inc. Controlled Pharmacokinetic Improvement of Peptides by Elastin-Like Polymers |
|
| Volker Stadler, German Cancer Research Center High Density Peptide Arrays for Biomarker Profiling |
|
| Paul Watt, Phylogica Ltd. From Phylomer to Phenotype: Discovering Bioactive Peptides in Phenotypic and Target Directed Screens of Phylomer Libraries |
|
| Hal Padgett, Novici Biotech LLC Gene Shuffling Technology For Directed Evolution Of Large And Small Proteins |
|
| Nicolas Mourier, Peptimmune Inc. Challenges And Solutions In Analytical Method Development For Peptide Copolymer Mixtures |
|
| John Tolle, Abbott Laboratories Evolution Of The Synthetic Process For Abt-510 |
|
| Hanomi Naora, University of Texas MD Anderson Cancer Center A peptide-based therapeutic approach to inhibit the translational machinery in tumors |
|
| Duu-Gong Wu, PharmaNet Expectations for Impurity Specifications in Peptide Therapeutics |
|
| Soumitra Ghosh, Amylin Integrated Neurohormonal Therapy for Obesity |
|
| Angelika Fretzen, Ironwood Pharma Linaclotide, a first-in-class, guanylate cyclase C agonist in development for the treatment of irritable bowel syndrome with constipation and chronic constipation. |
|
| Chris Roberts, Roche Colorado Corporation Scale-up and development of an MC-4 agonist |
|
| Les Miranda, Amgen Identification of Potent, Selective, and Metabolically Stable Peptide Antagonists to the Calcitonin Gene-Related Peptide (CGRP) Receptor |
|
| Bruce Morimoto, Allon Neuroprotection by AL-108: A case study for development of a CNS-active peptide as a treatment for Alzheimer’s Disease |
|
| Richard Duke, Apoplogic Breceptin: Pre-clinical data and clinical development plans for a peptide-based bradykinin antagonist in small cell lung cancer |
|
| Claudio Mapelli, Bristol Myers-Squibb A Novel Class of 11-MER Peptide Agonists of the GLP-1 Receptor |
|
| Soren Kjaerulff, Novozymes NZ2114 Plectasin, a new antibiotic for treatment of resistant Gram positive bacterial infections |
|
| Karsten Lundgren, 7TM Pharma Development of Y2 and Y4 GI-tract satiety signals as anti-obesity agents |
|
| John H. A. Amery, Pfizer An Industry Perspective on the Use of Bioassays for Synthetic Peptide and Nucleotide Pharmaceuticals |
|
| Rushia Turner, University of Califonia Santa Cruz Using Click Chemistry to Synthesize and Study the Relative Permeabilities of Cyclic Peptides and Their Linear Precursors. |
|
| Gunnar Kaufmann, The Scripps Research Institute Bacterial Quorum Sensing as Target for Anti-infective Therapy |
|
| Paul Wentworth, The Scripps Research Institute /Oxford University A Chemical Link Between Inflammation and Protein Misfolding Diseases |
|
| Ted Randolph, University of Colorado Conformational and Colloidal Contributions to Stability against Aggregation of Proteins |
|
| Robert P. Hammer, Louisiana State University Amino Acid Analogues in the Design of Functional Peptide Mimics |
|
| Stephen Kent, University of Chicago Total Chemical Synthesis of Proteins |
|
| Derek MacMillan, University College London Developments in the synthesis of post-translationally modified proteins employing native chemical ligation |
|
| Phil Dawson, The Scripps Research Institute Adaptive ligation reactions for the manipulation and assembly of peptides in aqueous solution |
|
| Tom Muir, Rockefeller University Protein Semisynthesis |
|
| Mike Selsted, Resolve Therapeutics Effector and Modulatory Activities of Antimicrobial Theta Defensins |
|
| Brian Bray, Trimeris T1144, Our Next Generation Fusion Inhibitor |
|
| Dennis B. Henriksen, Sanos Bioscience A/S GLP-2 and the Gut Feeling of Bone Remodeling | |
| Michael Fitzgerald, Duke University SUPREX: A Mass Spectrometry- and H/D Exchange-Based Method for the Investigation of Protein Folding and Function |
|
| Floyd Romesburg, The Scripps Research Institute High structural and temporal resolution probes of protein dynamics |
|
| Roger Micheli, Roche Colorado A Novel Spectroscopic Evaluation of Peptide Secondary Structure |
|
| Annelise Barron, Stanford University Peptoid mimics of cationic antimicrobial peptides |
|
| Chris Schafmeister, University of Pittsburgh Development and applications of shape-programmable molecules |
|
| Kevin Healy, UC Berkeley Peptide Imbibed Hydrogels to Control Stem Cell Fate |
|
| Waleed Danho, Hoffman-La Roche Opportunities and Challenges of Developing Peptide Drugs in the Pharmaceutical Industry |
|
| Shibo Jiang, New York Blood Center/Lindsley Kimball Research Institute HIV fusion inhibitory peptides and their mechanisms of action |
|
| Michael Carrasco, Santa Clara University Post-translational modifications of synthetic peptides using N-alkylaminooxy amino acids |
|
| Shelli McAlpine, San Diego State University Macrocyclic peptides as antitumor agents: SAR and mechanistic studies in pancreatic and colon cancers |
|
| Dewey McCafferty, Duke University To Stop a Determined Bacterial Pathogen |
|
| John Mayer, Eli Lilly and Co. Cyclic ß-MSH Peptides as Novel Anti-Obesity Agents |
|
| John Stewart, University of Colorado Health Sciences Center Bradykinin antagonists as potential anti-cancer drugs |
|
| Peter Wipf, University of Pittsburgh Parallel Synthesis and Biological Evaluation of Peptide Bond Isosteres |
|
| Steven Castle, Brigham Young University Progress Towards the Total Synthesis of Celogentin C |
|
| Akira Otaka, University of Tokushima Amide bond cleavage for the preparation of functional peptides |
|
| John Vederas, University of Alberta Synthesis and biological activity of peptide analogs having sulfur replaced by carbon or oxygen |
|
| David Teplow, UCLA The chemical biology of Alzheimer’s disease – A paradigm for molecular medicine |
|
| Aphrodite Kapurniotu, University Hospital RWTH-Aachen A designed peptide cross-amyloid disease inhibitor uncovers a molecular link between Alzheimer’s disease and type 2 diabetes |
